Skip to main content

Find Clinical Trials

Home
Conditions
Newly Diagnosed Mixed Phenotype Acute Leukemia

Clinical trial condition

Newly Diagnosed Mixed Phenotype Acute Leukemia

Explore clinical trials studying Newly Diagnosed Mixed Phenotype Acute Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Newly Diagnosed Mixed Phenotype Acute Leukemia trial results

Not Yet Recruiting

A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia

NCT07573670

Conditions: Newly Diagnosed Mixed Phenotype Acute Leukemia
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details